The U.S. Department of Health and Human Services established the risk adjustment data validation (RADV) program as a mechanism to protect risk adjustment integrity by assessing certain data elements supporting risk transfers. This white paper evaluates the implications of the RADV from the perspective of issuer results with an eye for what the actual impacts say about the program’s performance.